ReviewOne health (Amsterdam, Netherlands)2026
MediLabSecure: A decade of One Health actions to prevent emerging vector-borne diseases in the Mediterranean, Sahel and Black Sea regions.
Review in One health (Amsterdam, Netherlands), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
25 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The rising incidence of vector-borne diseases driven by environmental degradation and climate change poses significant risks for human health. The implementation of integrated surveillance systems is of paramount importance to efficiently mitigate their emergence and spread. MediLabSecure (MLS) is a pioneer One Health network launched by the European Union in 2014 to strengthen preparedness and response capacities to tackle vector-borne diseases (VBD) in the Mediterranean, Black Sea and Sahel regions, which are known hotspots for endemic and emerging vector-borne pathogens. MLS unites experts from human health, animal health and entomology across 24 countries to foster cross-sectoral collaboration through capacity building, networking, and regional cooperation. By promoting the development and implementation of integrated surveillance systems, MLS facilitates coordinated pathogen detection, vector monitoring, risk assessment, and control strategies that encompass the human-animal-environment interface. Over its ten-year history, the network has substantially strengthened technical capacities enabling improved arbovirus detection in human and animal samples, vector identification mapping and control, and integrated surveillance and risk assessment. The network experience demonstrates the critical importance of coordinated multisectoral actions, regional partnerships, and long-term investments in capacity building to combat existing and future health threats at the human-animal-environment interface. The bottom-up approach of the project, tailored to the specific needs of the beneficiary countries along with its long-term implementation - which fostered trust and stable collaborative initiatives - were key factors contributing to the success of MLS. This unique project offers a valuable blueprint for other regions aiming to implement One Health strategies to address complex transboundary public health challenges.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.